Kun-Liang Feng

Kun-Liang Feng

Auto-generated profile, based on publicly available information

Kun-Liang Feng

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CXChun-Feng Xie
Chun-Feng Xie
KFKun-Liang Feng
Kun-Liang Feng
JWJi-Nan Wang
Ji-Nan Wang
RLRui Luo
Rui Luo
CFChongkai Fang
Chongkai Fang
CZChong Zhong
Chong Zhong

26 April 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
LLLi-Hua Liu
Li-Hua Liu
CFChongkai Fang
Chongkai Fang
FGFu-Cheng Ge
Fu-Cheng Ge
JWJi-Nan Wang
Ji-Nan Wang
XZXiu-Bing Zhang
Xiu-Bing Zhang
CZChong Zhong
Chong Zhong
Background. Studies have shown that Jianpi Huayu Decoction (JPHYD) can inhibit the growth of hepatocellular carcinoma cells, but the mechanism of its effect was not clear at present. Methods. We assessed the effect of JPHYD using liver cancer cells as in vitro cell model and xenograft tumor as in vivo model. CCK8, EdU, wound-healing, and transwell assays were performed to assess the cell growth, migration, and invasion of hepatocellular carcinoma (HCC) cell lines HepG2 and MHCC97H. Western blot assay was performed to observe the protein level of E-cadherin, Smad7, N-cadherin, Snail, Smad3, Vimentin, and Zeb1. qRT-PCR assay was used to observe the expression of miR-21-5p in clinical liver cancer tissue samples and in HepG2 and MHCC97H cells. Animal tumorigenesis experiments and in vivo imaging experiments were performed to assess the results of in vitro experiments. Results. We found that JPHYD could inhibit the proliferation, invasion, and migration of hepatocellular carcinoma cells and JPHYD decreased the level of N-cadherin, Snail, Vimentin, Smad3, and Zeb1 and increased E-cadherin and Smad7 proteins. The expression of miR-21-5p was increased while that protein of Smad7 was decreased in HCC tissues. The vivo experiments also showed that miR-21-5p could promote the migration of HCC cells. JPHYD decreased miR-21-5p expression. The same results have been found in animal studies. Conclusion. Our results indicated that JPHYD inhibited epithelial-mesenchymal transition by increasing Smad7 expression and inhibiting miR-21-5p. Therefore, blocking the occurrence and development of EMT may be a new mechanism of JPHYDs anti-liver cancer effect.